Facing the Future of Brain Tumor Clinical Research
作者： Mark R. Gilbert , Terri S. Armstrong , Whitney B. Pope , Martin J. van den Bent , Patrick Y. Wen
DOI: 10.1158/1078-0432.CCR-14-0835
关键词: Clinical trial 、 Brain tumor 、 Pediatric Brain Tumor 、 Clinical research 、 Patient treatment 、 Clinical study design 、 Cancer 、 Medical physics 、 Pathology 、 Medicine 、 Pediatric brain
摘要: This edition of CCR Focus provides critical reviews several important areas in the field, including application findings from genomic investigations brain tumors to improve diagnosis, clinical trial design, and ultimately optimizing individual patient treatment. Another article is a review provided by experts field that discusses recent trials using angiogenesis inhibitors, possible explanations for results, how move forward. There concise discussion immunotherapy key investigators this reflecting potential opportunities as well disease-specific challenges. Finally, leading pediatric tumor provide an overview insights about seminal discoveries two tumors, supporting paradigm laboratory lead more precise prognosis, better Herein, advances challenges area translational research set stage contributions follow. See all articles section, “Discoveries, Challenges, Progress Primary Brain Tumors.” Clin Cancer Res; 20(22); 5591–600. ©2014 AACR .
aacrjournals.org
sci-hub.se 参考文章(73)
S. L. Rankin, G. Zhu, S. J. Baker, Review: insights gained from modelling high-grade glioma in the mouse. Neuropathology and Applied Neurobiology. ,vol. 38, pp. 254- 270 ,(2012) , 10.1111/J.1365-2990.2011.01231.X
Katherine E. Warren, Tina Y. Poussaint, Gilbert Vezina, Darren Hargrave, Roger J. Packer, Stewart Goldman, Patrick Y. Wen, Ian F. Pollack, David Zurakowski, Larry E. Kun, Michael D. Prados, Stefan Rutkowski, Mark W. Kieran, Challenges with defining response to antitumor agents in pediatric neuro-oncology: A report from the response assessment in pediatric neuro-oncology (RAPNO) working group Pediatric Blood & Cancer. ,vol. 60, pp. 1397- 1401 ,(2013) , 10.1002/PBC.24562
Nader Sanai, Mitchel S. Berger, Recent surgical management of gliomas. Advances in Experimental Medicine and Biology. ,vol. 746, pp. 12- 25 ,(2012) , 10.1007/978-1-4614-3146-6_2
Eric T. Wong, Kenneth R. Hess, Mary Jo Gleason, Kurt A. Jaeckle, Athanassios P. Kyritsis, Michael D. Prados, Victor A. Levin, W.K. Alfred Yung, Outcomes and Prognostic Factors in Recurrent Glioma Patients Enrolled Onto Phase II Clinical Trials Journal of Clinical Oncology. ,vol. 17, pp. 2572- 2578 ,(1999) , 10.1200/JCO.1999.17.8.2572
Steven S Brem, Philip J Bierman, Henry Brem, Nicholas Butowski, Marc C Chamberlain, Ennio A Chiocca, Lisa M DeAngelis, Robert A Fenstermaker, Allan Friedman, Mark R Gilbert, Deneen Hesser, Larry Junck, Gerald P Linette, Jay S Loeffler, Moshe H Maor, Madison Michael, Paul L Moots, Tara Morrison, Maciej Mrugala, Louis Burt Nabors, Herbert B Newton, Jana Portnow, Jeffrey J Raizer, Lawrence Recht, Dennis C Shrieve, Allen K Sills, Frank D Vrionis, Patrick Y Wen, Central Nervous System Cancers Journal of The National Comprehensive Cancer Network. ,vol. 11, pp. 1114- 1151 ,(2011) , 10.6004/JNCCN.2013.0132
Christina A Meyers, Kenneth R Hess, WK Alfred Yung, Victor A Levin, None, Cognitive Function as a Predictor of Survival in Patients With Recurrent Malignant Glioma Journal of Clinical Oncology. ,vol. 18, pp. 646- 650 ,(2000) , 10.1200/JCO.2000.18.3.646
D R Macdonald, T L Cascino, S C Schold, J G Cairncross, Response criteria for phase II studies of supratentorial malignant glioma. Journal of Clinical Oncology. ,vol. 8, pp. 1277- 1280 ,(1990) , 10.1200/JCO.1990.8.7.1277
T.S. Armstrong, T. Mendoza, I. Gring, C. Coco, M.Z. Cohen, L. Eriksen, Ming-Ann Hsu, M.R. Gilbert, C. Cleeland, Validation of the M.D. Anderson Symptom Inventory Brain Tumor Module (MDASI-BT). Journal of Neuro-oncology. ,vol. 80, pp. 27- 35 ,(2006) , 10.1007/S11060-006-9135-Z
N. Sanai, M.S. Berger, Extent of resection influences outcomes for patients with gliomas. Revue Neurologique. ,vol. 167, pp. 648- 654 ,(2011) , 10.1016/J.NEUROL.2011.07.004
Maciej S. Lesniak, Robert Langer, Henry Brem, Drug delivery to tumors of the central nervous system Current Neurology and Neuroscience Reports. ,vol. 1, pp. 210- 216 ,(2001) , 10.1007/S11910-001-0020-Z